iCAD, Inc. (ICAD)
3.870
+0.140 (3.75%)
Inactive · Last trade price on Jul 16, 2025

Company Description

iCAD, Inc. provides AI-powered cancer detection solutions in the United States.

The company’s ProFound Breast Health Suite offers solutions for breast cancer detection, breast density assessment, one- or two-year breast cancer risk evaluation, and cardiovascular risk assessment related to elevated levels of breast arterial calcifications; and enables medical providers and professionals to accurately and reliably identify where cancer may be hiding.

Its Detection solutions include advanced artificial intelligence and image analysis workflow solutions to identifying pathologies and pinpointing prevalent cancers earlier; and a range of upgradeable computer-aided detection systems and workflow solutions for digital breast tomosynthesis, full-field digital mammography, magnetic resonance imaging, and computed tomography.

In addition, the company suite offers solutions for cancer detection, density assessment, and personalized risk evaluation based on a 2D or 3D mammogram’s collection of images.

Additionally, its density assessment standardizes and simplifies breast density reporting by algorithmically examining a woman’s breast anatomy from the mammogram image.

The company was formerly known as Howtek, Inc. and changed its name to iCAD, Inc. in June 2002. iCAD, Inc. was incorporated in 1984 and is headquartered in Nashua, New Hampshire.

iCAD, Inc.
iCAD, Inc. logo
CountryUnited States
Founded1984
IPO DateDec 3, 1986
IndustryMedical Devices
SectorHealthcare
Employees66
CEODana Brown

Contact Details

Address:
2 Townsend West, Suite 6
Nashua, New Hampshire 03063
United States
Phone603 882 5200
Websiteicadmed.com

Stock Details

Ticker SymbolICAD
ExchangeNASDAQ
Stock TypeCommon Stock
Fiscal YearJanuary - December
Reporting CurrencyUSD
CIK Code0000749660
CUSIP Number44934S206
ISIN NumberUS44934S2068
Employer ID02-0377419
SIC Code3841

Key Executives

NamePosition
Dana R. BrownPresident, Chief Executive Officer and Executive Chair
Eric LonnqvistChief Financial Officer
Jonathan GoChief Technology Officer
Michelle StrongChief Operations Officer
Annette L. HerouxVice President of Administration
Brian TestaChief People Officer
Bill KeyesSenior Vice President of Global Sales Operations
Vasu AvadhanulaChief Product Officer
Peter GrahamSenior Vice President of North American Sales
Mark KoeniguerChief Commercial Officer

Latest SEC Filings

DateTypeTitle
Jul 17, 2025S-8 POSSecurities to be offered to employees in employee benefit plans, post-effective amendments
Jul 17, 2025S-8 POSSecurities to be offered to employees in employee benefit plans, post-effective amendments
Jul 17, 2025S-8 POSSecurities to be offered to employees in employee benefit plans, post-effective amendments
Jul 17, 2025S-8 POSSecurities to be offered to employees in employee benefit plans, post-effective amendments
Jul 17, 2025S-8 POSSecurities to be offered to employees in employee benefit plans, post-effective amendments
Jul 17, 2025S-8 POSSecurities to be offered to employees in employee benefit plans, post-effective amendments
Jul 17, 2025S-8 POSSecurities to be offered to employees in employee benefit plans, post-effective amendments
Jul 17, 2025S-8 POSSecurities to be offered to employees in employee benefit plans, post-effective amendments
Jul 17, 2025S-8 POSSecurities to be offered to employees in employee benefit plans, post-effective amendments
Jul 17, 2025S-8 POSSecurities to be offered to employees in employee benefit plans, post-effective amendments